Decoding 3D chromatin architecture reveals distinct enhancer classes underlying hierarchical gene regulation in prostate cancer [ChIP-Seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 24 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 24 samples: 12 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Decoding 3D chromatin architecture reveals distinct enhancer classes underlying hierarchical gene regulation in prostate cancerGenome biology · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE314776_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1392579 and SRA study SRP657432. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 12 replicated groups read from 24 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9410328 22Rv1_H3K27ac_NTC_R1 22Rv1_H3K27ac_NTC
- GSM9410329 22Rv1_H3K27ac_NTC_R2 22Rv1_H3K27ac_NTC
- GSM9410330 22Rv1_H3K27ac_cPCE_del_R1 22Rv1_H3K27ac_cPCE_del
- GSM9410331 22Rv1_H3K27ac_cPCE_del_R2 22Rv1_H3K27ac_cPCE_del
- GSM9410332 22Rv1_H3K27ac_rPCE_del_R1 22Rv1_H3K27ac_rPCE_del
- GSM9410333 22Rv1_H3K27ac_rPCE_del_R2 22Rv1_H3K27ac_rPCE_del
- GSM9410334 22Rv1_H3K27ac_resPCE_del_R1 22Rv1_H3K27ac_resPCE_del
- GSM9410335 22Rv1_H3K27ac_resPCE_del_R2 22Rv1_H3K27ac_resPCE_del
- GSM9410340 22Rv1_CTCF_NTC_R1 22Rv1_CTCF_NTC
- GSM9410341 22Rv1_CTCF_NTC_R2 22Rv1_CTCF_NTC
- GSM9410342 22Rv1_CTCF_cPCE_del_R1 22Rv1_CTCF_cPCE_del
- GSM9410343 22Rv1_CTCF_cPCE_del_R2 22Rv1_CTCF_cPCE_del
- GSM9410344 22Rv1_FOXA1_NTC_R1 22Rv1_FOXA1_NTC
- GSM9410345 22Rv1_FOXA1_NTC_R2 22Rv1_FOXA1_NTC
- GSM9410346 22Rv1_FOXA1_cPCE_del_R1 22Rv1_FOXA1_cPCE_del
- GSM9410347 22Rv1_FOXA1_cPCE_del_R2 22Rv1_FOXA1_cPCE_del
- GSM9410348 22Rv1_FOXA1_rPCE_del_R1 22Rv1_FOXA1_rPCE_del
- GSM9410349 22Rv1_FOXA1_rPCE_del_R2 22Rv1_FOXA1_rPCE_del
- GSM9410350 22Rv1_CTCF_rPCE_del_R1 22Rv1_CTCF_rPCE_del
- GSM9410351 22Rv1_CTCF_rPCE_del_R2 22Rv1_CTCF_rPCE_del
- GSM9806579 RC77NE_H3K27ac_R1 RC77NE_H3K27ac
- GSM9806580 RC77NE_H3K27ac_R2 RC77NE_H3K27ac
- GSM9806581 RC77TE_H3K27ac_R1 RC77TE_H3K27ac
- GSM9806582 RC77TE_H3K27ac_R2 RC77TE_H3K27ac
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE314777 Decoding 3D chromatin architecture reveals distinct enhancer classes underlying hierarchical gene regulation in prostate cancer 10 samples shares architecture, hierarchical, underlying, chromatin, decoding, distinct, enhancer, prostate
- GSE215328 Pivotal Role of the NuRD Complex in Remodeling Chromatin Environment and Maintaining Genome Architecture at CTCF Sites [hESC_H9_d049_ChIP_Seq] 135 samples shares architecture, chromatin
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.